drugset / Trial / NCT02779348
Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine whether multiple-dose administration of nebicapone affects the pharmacokinetics of warfarin.
Timeline
- Start
- 2006-09
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIA 3-202 | Unknown | 200 mg | — |
| Subject | Warfarin | Small molecule | 25 mg | — |
Indications
No indication recorded.